Nashik

Maharashtra Knowledge Corporation Limited (MKCL) was promoted by the Department of Higher and Technical Education, Government of Maharashtra, India and was incorporated under the Companies Act, 1956 on August 20, 2001 as a Public Limited Company under CIN. U 80302 MH 2001 PLC 133101 to create new paradigm in education and development through universalization and integration of Information Technology in teaching, learning and educational management processes in particular and socio-economic transformative processes in general.

Post: Laboratory Assistant

one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in approximately 140 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. With a workforce of more than 20,000, has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service.
one of the world’s largest active pharmaceutical ingredient (API) manufacturers. one of only two global generics companies with a comprehensive, vertically integrated supply chain. also is one of the world’s largest producers of API used to make generic antiretroviral (ARV) therapies for the treatment of HIV/AIDS.

Post: Sr Manager SCM (Demand and Supply Planing)

The Public Health Department Government of Maharashtra, is making constant and concerted effort to formulate and execute schemes to ensure adequate health care services to the people in line with the National Health Policy. While implementing these schemes, steps are being taken to make improvements in the health care system in the State to cater to the health needs of the people in the rural areas, particularly in the tribal and backward regions of the State.

Post: Pharmacist

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 4000 people. Globally, we are a £ 27.4 billion, leading, research-based healthcare and pharmaceutical company. In India, we are one of the market leaders. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer.

ABOUT AUTHORS:
Madhuri D. Ghadage*¹, Gajanan H. Banapure^2
1Department of Pharmaceutics, SMBT College of Pharmacy, Dhamangaon, Nashik
²H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur Dhule
*maadhuri.ghadge@gmail.com

ABSTRACT
The controlled release of drugs in slow and sustained manner is one of the major challenges in drug delivery system. Targeting of drug to the particular site is an important aspect of drug delivery system. Carrier technology offers an intelligent approach for drug delivery by coupling the drug to a carrier particle such as microsphere which modulates the release and absorption characteristics of the drug. These delivery systems offer numerous advantages over the conventional dosage forms including improved efficacy, reduced toxicity, and improved patient compliance. Microspheres received much attention not only for prolonged release, but also for targeting of anticancer drugs. In future microspheres will find the central place in novel drug delivery, particularly in diseased cell sorting, diagnostics, genetic materials, targeted and effective drug delivery. The current aim of this review is to study various aspects of the microparticulates drug delivery system including method of formulation, evaluation & characterization.

Mylan ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world’s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies.

Mylan ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world’s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies.

Mylan ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world’s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies.